Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage

REFERENCES

• Dorsch NW. Cerebral arterial spasm—a clinical review. Br 1 Neurosurg 1995; 9: 403–412
   PubMed Web of Science ®Google Scholar
• Ecker A, Riemenschneider PA. Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms. I Neurosurg 1951; 8: 660–667
   PubMed Web of Science ®Google Scholar
• Walton JN. The prognosis and management of subarachnoid haemorrhage. Can Med Assoc 11955; 72: 165–175
   PubMedGoogle Scholar
• Rousseaux P, Scherpereel B, Bernard MH, et al. Fever and cerebral vasospasm in ruptured intracranial aneurysms. Surg Neurol 1980; 14: 459–465
   PubMedGoogle Scholar
• Weir B, Disney L, Grace M, et al. Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm. Neurosurgery 1989; 25: 161–165
   PubMed Web of Science ®Google Scholar
• Oliveira-Filho J, Ezzeddine MA, Segal AZ, et al. Fever in subarachnoid hemorrhage: Relationship to vasospasm and out-come. Neurology 2001; 56: 1299-1304
   Google Scholar
• Neil-Dwyer G, Cruickshank J. The blood leucocyte count and its prognostic significance in subarachnoid haemorrhage. Brain 1974; 97: 79–86
   PubMed Web of Science ®Google Scholar
• Spallone A, Acqui M, Pastore FS, et al. Relationship between leukocytosis and ischemic complications following aneurysmal subarachnoid hemorrhage. Surg Neurol 1987; 27: 253–258
   PubMedGoogle Scholar
• Niikawa S, Hara S, Ohe N, et al. Correlation between blood parameters and symptomatic vasospasm in subarachnoid hemor-rhage patients. Neurol Med Chir (Tokyo) 1997; 37: 881–884
   PubMedGoogle Scholar
• Maiuri F, Gallicchio B, Donati P, et al. The blood leukocyte count and its prognostic significance in subarachnoid hemor-rhage. I Neurosurg Sci 1987; 31: 45–48
   PubMedGoogle Scholar
• McGirt MJ, Mavropoulos JC, McGirt LY, et al. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. I Neurosurg 2003; 98: 1222–1226
   PubMed Web of Science ®Google Scholar
• Pellettieri L, Carlson CA, Lindholm L. Is the vasospasm following subarachnoidal hemorrhage an immunoreactive disease? Experientia 1981; 37: 1170–1171
   PubMedGoogle Scholar
• Pellettieri L, Nilsson B, Carlsson CA, et al. Serum immunocom-plexes in patients with subarachnoid hemorrhage. Neurosurgery 1986; 19: 767–771
   PubMed Web of Science ®Google Scholar
• Ostergaard JR, Kristensen BO, Svehag SE, et al. Immune complexes and complement activation following rupture of intracranial saccular aneurysms. J Neurosurg 1987; 66: 891–897
   PubMed Web of Science ®Google Scholar
• Kasuya H, Shimizu T. Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarach-noid hemorrhage. J Neurosurg 1989; 71: 741–746
   PubMed Web of Science ®Google Scholar
• Crompton MR. The pathogenesis of cerebral infarction following the rupture of cerebral berry aneurysms. Brain 1964; 87: 491–510
   PubMed Web of Science ®Google Scholar
• Hughes JT, Schianchi PM. Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 1978; 48: 515-525
   Google Scholar
• Ryba M, Jarzabek-Chorzelska M, Chorzelski T, et al. Is vascular angiopathy following intracranial aneurysm rupture immunolo-gically mediated? Acta Neurochir (Wien) 1992; 117: 34–37
   PubMed Web of Science ®Google Scholar
• Hoshi T, Shimizu T, Kito K, et al. [Immunological study of late cerebral vasospasm in subarachnoid hemorrhage. Detection of immunoglobulins, C3, and fibrinogen in cerebral arterial walls by immunofluorescence method]. Neurol Med Chir (Tokyo) 1984; 24: 647–654
   PubMedGoogle Scholar
• Tanabe Y, Sakata K, Yamada H, et al. Cerebral vasospasm and ultrastructural changes in cerebral arterial wall. An experimental study. J Neurosurg 1978; 49: 229–238
   PubMed Web of Science ®Google Scholar
• Liszczak TM, Varsos VG, Black PM, et al. Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall. J Neurosurg 1983; 58: 18–26
   PubMed Web of Science ®Google Scholar
• Handa Y, Kabuto M, Kobayashi H, et al. The correlation between immunological reaction in the arterial wall and the time course of the development of cerebral vasospasm in a primate model. Neurosurgery 1991; 28: 542–549
   PubMed Web of Science ®Google Scholar
• Yamashima T, Yamamoto S. Cerebral arterial pathology in experimental subarachnoid hemorrhage. J Neurosurg 1983; 58: 843–850
   PubMed Web of Science ®Google Scholar
• Kubota T, Handa Y, Tsuchida A, et al. The kinetics of lymphocyte subsets and macrophages in subarachnoid space after subarach-noid hemorrhage in rats. Stroke 1993; 24: 1993–2000
   PubMed Web of Science ®Google Scholar
• Peterson JW, Kwun BD, Hackett JD, et al. The role of inflammation in experimental cerebral vasospasm. J Neurosurg 1990; 72: 767–774
   PubMed Web of Science ®Google Scholar
• Yanamoto H, Kikuchi H, Okamoto S, et al. Cerebral vasospasm caused by cisternal injection of polystyrene latex beads in rabbits is inhibited by a serine protease inhibitor. Surg Neurol 1994; 42: 374–381
   PubMedGoogle Scholar
• Nagata K, Sasaki T, Mori T, et al. Cisternal talc injection in dog can induce delayed and prolonged arterial constriction resem-bling cerebral vasospasm morphologically and pharmacologi-cally. Surg Neurol 1996; 45: 442–447
   PubMedGoogle Scholar
• Chyatte D, Sundt TM, Jr. Response of chronic experimental cerebral vasospasm to methylprednisolone and dexamethasone. J Neurosurg 1984; 60: 923–926
   PubMed Web of Science ®Google Scholar
• Chyatte D. Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone. Stroke 1989; 20: 1021–1026
   PubMed Web of Science ®Google Scholar
• Chyatte D, Rusch N, Sundt TM, Jr. Prevention of chronic experimental cerebral vasospasm with ibuprofen and high-dose methyl prednisolone. J Neurosurg 1983; 59: 925–932
   PubMed Web of Science ®Google Scholar
• Yamakawa K, Sasaki T, Tsubaki S, et al. Effect of high-dose methylprednisolone on vasospasm after subarachnoid hemor-rhage. Neurol Med Chir (Tokyo) 1991; 31: 24–31
   PubMedGoogle Scholar
• Chyatte D, Fode NC, Nichols DA, et al. Preliminary report: Effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1987; 21: 157–160
   PubMed Web of Science ®Google Scholar
• Hashi K, Takakura K, Sano K, et al. [Intravenous hydrocortisone in large doses in the treatment of delayed ischemic neurological deficits following subarachnoid hemorrhage--results of a multi-center controlled double-blind clinical study]. No To Shinkei 1988; 40: 373–382
   PubMedGoogle Scholar
• Handa Y, Hayashi M, Takeuchi H, et al. Effect of cyclosporine on the development of cerebral vasospasm in a primate model. Neurosurgery 1991; 28: 380–385
   PubMed Web of Science ®Google Scholar
• Peterson JW, Nishizawa S, Hackett JD, et al. Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs. Stroke 1990; 21: 133–137
   PubMed Web of Science ®Google Scholar
• Manno EM, Gress DR, Ogilvy CS, et al. The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: A pilot study. Neurosurgery 1997; 40: 289–293
   PubMed Web of Science ®Google Scholar
• Ryba M, Pastuszko M, lwanska K, et al. Cyclosporine A prevents neurological deterioration of patients with SAH—a preliminary report. Acta Neurochir (Wien) 1991; 112: 25–27
   PubMed Web of Science ®Google Scholar
• Ryba M, Pastuszko M, Dziewiecki C, et al. A strategy for analyzing multiple parameters with application to aneurysmal SAH patients all of them clipped but treated with and without cyclosporine. Acta Neurochir (Wien) 1993; 122: 194–199
   PubMed Web of Science ®Google Scholar
• Mori T, Nagata K, Ishida T, et al. FK-506: A new immunosup-pressive agent, failed to reduce cerebral vasospasm after experimental subarachnoid hemorrhage. J Vet Med Sci 1993; 55: 581–586
   PubMed Web of Science ®Google Scholar
• Nagata K, Sasaki T, lwama J, et al. Failure of FK-506, a new immunosuppressant, to prevent cerebral vasospasm in a canine two-hemorrhage model. J Neurosurg 1993; 79: 710–715
   PubMed Web of Science ®Google Scholar
• Nishizawa S, Peterson JW, Shimoyama I, et al. Therapeutic effect of a new immunosuppressant, FK-506, on vasospasm after subarachnoid hemorrhage. Neurosurgery 1993; 32: 986–991
   PubMed Web of Science ®Google Scholar
• German JW, Gross CE, Giclas P, et al. Systemic complement depletion inhibits experimental cerebral vasospasm. Neurosurgery 1996; 39: 141–145
   PubMed Web of Science ®Google Scholar
• Yanamoto H, Kikuchi H, Okamoto S. Effects of protease inhibitor and immunosuppressant on cerebral vasospasm after subarach-noid hemorrhage in rabbits. Surg Neurol 1994; 42: 382–387
   PubMedGoogle Scholar
• Yanamoto H, Kikuchi H, Okamoto S, et al. Preventive effect of synthetic serine protease inhibitor, FUT-175, on cerebral vasospasm in rabbits. Neurosurgery 1992; 30: 351–356
   PubMed Web of Science ®Google Scholar
• Yanamoto H, Kikuchi H, Sato M, et al. Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT-175, administered in the acute stage after subarachnoid hemorrhage. Neurosurgery 1992; 30: 358–363
   PubMed Web of Science ®Google Scholar
• Kaminogo M, Yonekura M, Onizuka M, et al. Combination of serine protease inhibitor FUT-175 and thromboxane synthetase inhibitor OKY-046 decreases cerebral vasospasm in patients with subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 1998; 38: 704–708
   PubMed Web of Science ®Google Scholar
• White RP, Robertson JT. Comparison of piroxicam, meclofena-mate, ibuprofen, aspirin, and prostacyclin efficacy in a chronic model of cerebral vasospasm. Neurosurgery 1983; 12: 40–46
   PubMed Web of Science ®Google Scholar
• Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301–314
   PubMed Web of Science ®Google Scholar
• Handa Y, Kubota T, Kaneko M, et al. Expression of intercellular adhesion molecule 1 (ICAM-1) on the cerebral artery following subarachnoid haemorrhage in rats. Acta Neurochir (Wien) 1995; 132: 92–97
   PubMed Web of Science ®Google Scholar
• Sills AK, Jr, Clatterbuck RE, Thompson RC, et al. Endothelial cell expression of intercellular adhesion molecule 1 in experimental posthemorrhagic vasospasm. Neurosurgery 1997; 41: 453–460
   PubMed Web of Science ®Google Scholar
• Polin RS, Bavbek M, Shaffrey ME, et al. Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 1998; 89: 559–567
   PubMed Web of Science ®Google Scholar
• Nissen JJ, Mantle D, Gregson B, et al. Serum concentration of adhesion molecules in patients with delayed ischaemic neurolo-gical deficit after aneurysmal subarachnoid haemorrhage: The immunoglobulin and selectin superfamilies. J Neurol Neurosurg Psychiatry 2001; 71: 329–333
   PubMed Web of Science ®Google Scholar
• Mack WJ, Mocco J, Hoh DJ, et al. Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002; 96: 71–75
   PubMed Web of Science ®Google Scholar
• Mocco J, Mack WJ, Kim GH, et al. Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm follow-ing aneurysmal subarachnoid hemorrhage.] Neurosurg 2002; 97: 537–541
   PubMed Web of Science ®Google Scholar
• Kaynar MY, Tanriverdi T, Kafadar AM, et al. Detection of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage. J Neurosurg 2004; 101: 1030–1036
   PubMed Web of Science ®Google Scholar
• Cheong JH, Kim JM, Bak KH, et al. Correlation between cerebral vasospasm after subarachnoid hemorrhage and intercellular adhesion molecule-1 levels in serum and cerebrospinal fluid. J Korean Neurosurg Soc 2005; 38: 1-11
   Google Scholar
• Aihara Y, Kasuya H, Onda H, et al. Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 2001; 32: 212–217
   PubMed Web of Science ®Google Scholar
• Oshiro EM, Hoffman PA, Dietsch GN, et al. Inhibition of experimental vasospasm with anti-intercellular adhesion mole-cule-1 monoclonal antibody in rats. Stroke 1997; 28: 2031–2037
   PubMed Web of Science ®Google Scholar
• Bavbek M, Polin R, Kwan AL, et al. Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Stroke 1998; 29: 1930–1935
   PubMed Web of Science ®Google Scholar
• Clatterbuck RE, Oshiro EM, Hoffman PA, et al. Inhibition of vasospasm with lymphocyte function-associated antigen-1 mono-clonal antibody in a femoral artery model in rats. J Neurosurg 2002; 97: 676–682
   PubMed Web of Science ®Google Scholar
• Clatterbuck RE, Gail loud P, Ogata L, et al. Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal anti-body administered after experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg 2003; 99: 376–382
   PubMed Web of Science ®Google Scholar
• Pradilla G, Wang PP, Legnani FG, et al. Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits. J Neurosurg 2004; 101: 88–92
   PubMed Web of Science ®Google Scholar
• Lin CL, Dumont AS, Calisaneller T, et al. Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm. Surg Neurol 2005; 64: 201–205
   PubMedGoogle Scholar
• Kapiotis S, Sengoelge G, Sperr WR, et al. Ibuprofen inhibits pyrogen-dependent expression of VCAM-1 and ICAM-1 on human endothelial cells. Life Sci 1996; 58: 2167–2181
   PubMed Web of Science ®Google Scholar
• Hofbauer R, Speiser W, Kapiotis S. Ibuprofen inhibits leukocyte migration through endothelial cell monolayers. Life Sci 1998; 62: 1775–1781
   PubMed Web of Science ®Google Scholar
• Thai QA, Oshiro EM, Tamargo RJ. Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-release polymers. Stroke 1999; 30: 140–147
   PubMed Web of Science ®Google Scholar
• Frazier JL, Pradilla G, Wang PP, et al. Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage. J Neurosurg 2004; 101: 93–98
   PubMed Web of Science ®Google Scholar
• Pradilla G, Thai QA, Legnani FG, et al. Local delivery of ibuprofen via controlled-release polymers prevents angiographic vasospasm in a monkey model of subarachnoid hemorrhage. Neurosurgery 2005; 57: 184–190
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Lynch JR, Parra A, et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002; 33: 2950–2956
   PubMed Web of Science ®Google Scholar
• Tseng MY, Czosnyka M, Richards H, et al. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregula-tion, and delayed ischemic deficits after aneurysmal subarach-noid hemorrhage: A phase II randomized placebo-controlled trial. Stroke 2005; 36: 1627–1632
   PubMed Web of Science ®Google Scholar
• Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: Results of a pilot randomized clinical trial. Stroke 2005; 36: 2024–2026
   PubMed Web of Science ®Google Scholar
• Parra A, Kreiter KT, Williams S, et al. Effect of prior statin use on functional outcome and delayed vasospasm after acute aneur-ysmal subarachnoid hemorrhage: A matched controlled cohort study. Neurosurgery 2005; 56: 476–484
   PubMed Web of Science ®Google Scholar
• Weber C, Erl W, Weber KS, et al '.HMG-CoA reductase inhibitors decrease CDllb expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. J Am Coll Cardiol 1997; 30: 1212–1217
   PubMed Web of Science ®Google Scholar
• Kallen J, Welzenbach K, Ramage P, et al. Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. J Mol Biol 1999; 292: 1–9
   PubMed Web of Science ®Google Scholar
• Weitz-Schmidt G, Welzenbach K, Brinkmann V, et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 2001; 7: 687–692
   PubMed Web of Science ®Google Scholar
• Koh KK, Son JW, Ahn JY, et al. Vascular effects of diet and statin in hypercholesterolemic patients. Int J Cardiol 2004; 95: 185–191
   PubMed Web of Science ®Google Scholar
• Ascer E, Bertolami MC, Venturinelli ML, et al. Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis 2004; 177: 161–166
   PubMed Web of Science ®Google Scholar
• Rezaie-Majd A, Prager GW, Bucek RA, et al. Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2003; 23: 397–403
   PubMed Web of Science ®Google Scholar
• Chello M, Carassiti M, Agro F, et al. Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass.] Cardiothorac Vasc Anesth 2004; 18: 605–609
   PubMed Web of Science ®Google Scholar
• Doo YC, Han SJ, Han SW, et al. Effect of preexisting statin use on expression of C-reactive protein, adhesion molecules, interleu-kin-6, and antioxidized low-density lipoprotein antibody in patients with unstable angina undergoing coronary stenting. Clin Cardiol 2005; 28: 72–76
   PubMed Web of Science ®Google Scholar
• Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol 2002; 88: 227–249
   PubMedGoogle Scholar
• Manning AM, Davis RJ. Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov 2003; 2: 554–565
   PubMed Web of Science ®Google Scholar
• Yatsushige H, Yamaguchi M, Zhou C, et al. Role of c-Jun N-terminal kinase in cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke 2005; 36: 1538-1543
   Google Scholar
• Cuzzocrea S. Shock, inflammation and PARP. Pharmacol Res 2005; 52: 72–82
   PubMed Web of Science ®Google Scholar
• Satoh M, Date I, Nakajima M, et al. Inhibition of poly(ADP-ribose) polymerase attenuates cerebral vasospasm after subar-achnoid hemorrhage in rabbits. Stroke 2001; 32: 225–231
   PubMed Web of Science ®Google Scholar
• Tandea M, Kataoka K, Akai F, et al. Traumatic subarachnoid hemorrhage as a predictable indicator of delayed ischemic symptoms. J Neurosurg 1996; 84: 762–768
   PubMed Web of Science ®Google Scholar
• Hamer J, Krastel A. Cerebral vasospasm after brain injury. Neurochirurgia (Stuttg) 1976; 19: 185–189
   PubMedGoogle Scholar
• Martin NA, Doberstein C, Zane C, et al. Posttraumatic cerebral arterial spasm: Transcranial Doppler ultrasound, cerebral blood flow, and angiographic findings. J Neurosurg 1992; 77: 575–583
   PubMed Web of Science ®Google Scholar
• Sander D, Klingelhofer J. Cerebral vasospasm following post-traumatic subarachnoid hemorrhage evaluated by transcranial Doppler ultrasonography. J Neurol Sci 1993; 119: 1–7
   PubMed Web of Science ®Google Scholar
• Pasqualin A, Vivenza C, Rosta L, et al. Cerebral vasospasm after head injury. Neurosurgery 1984; 15: 855–858
   PubMed Web of Science ®Google Scholar
• Soustiel JF, Shik V. Posttraumatic basilar artery vasospasm. Surg Neurol 2004; 62: 201–206
   PubMedGoogle Scholar
• Zubkov AY, Lewis Al, Raila FA, et al. Risk factors for the development of post-traumatic cerebral vasospasm. Surg Neurol 2000; 53: 126–130
   PubMedGoogle Scholar
• Martin NA, Doberstein C, Alexander M, et al. Posttraumatic cerebral arterial spasm. J Neurotrauma 1995; 12: 897–901
   PubMed Web of Science ®Google Scholar
• Armin SS, Colohan ART, Zhang JH. Traumatic subarachnoid hemorrhage: our current understanding and its evolution over the past half century. Neurol Res 2006; 28: 445–452
   PubMed Web of Science ®Google Scholar
• Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 2006; 66: 232–245
   PubMed Web of Science ®Google Scholar
• Ries S, Schminke U, Fassbender K, et al. Cerebrovascular involvement in the acute phase of bacterial meningitis. J Neurol 1997; 244: 51–55
   PubMed Web of Science ®Google Scholar
• Yamashima T, Kashihara K, Ikeda K, et al. Three phases of cerebral arteriopathy in meningitis: Vasospasm and vasodilata-tion followed by organic stenosis. Neurosurgery 1985; 16: 546–553
   PubMed Web of Science ®Google Scholar
• Pfister HW, Borasio GD, Dirnagl U, et al. Cerebrovascular complications of bacterial meningitis in adults. Neurology 1992; 42: 1497–1504
   PubMed Web of Science ®Google Scholar
• Leeds NE, Goldberg HI. Angiographic manifestations in cerebral inflammatory disease. Radiology 1971; 98: 595–604
   PubMed Web of Science ®Google Scholar
• Ferris EJ, Rudikoff JC, Shapiro JH. Cerebral angiography of bacterial infection. Radiology 1968; 90: 727–734
   PubMed Web of Science ®Google Scholar
• Busse WW, Lemanske RF, Jr. Asthma. N Engl I Med 2001; 344: 350–362
   PubMed Web of Science ®Google Scholar
• Nosko M, Weir BK, Lunt A, et al. Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model. I Neurosurg 1987; 66: 416–422
   PubMed Web of Science ®Google Scholar
• Handa Y, Weir BK, Nosko M, et al. The effect of timing of clot removal on chronic vasospasm in a primate model. I Neurosurg 1987; 67: 558–564
   PubMed Web of Science ®Google Scholar
• Findlay JM, Weir BK, Kanamaru K, et al. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery 1990; 26: 201–206
   PubMed Web of Science ®Google Scholar